Alliance of Wound Care Stakeholders Busy Advocating for Members
The Alliance has been busy in submitting comments to legislative bodies and regulatory agencies. Click here for a complete list of our “Official Comments" section under the Activities and Achievements for the following comments submitted by the Alliance with our members' guidance and input:”
- August 2016-Alliance comments to CMS on CMS Patient Relationship Categories and Codes
- August 2016-Alliance comments to Noridian Local Coverage Determination (LCD) for Hyperbaric Oxygen (HBO) Therapy (DL 36686)
- August 2016-Alliance commentsto Cigna Government Services Local Coverage Determination (LCD) for Application of Skin Substitute for Wounds of Lower Extremities (DL36690)
- August 2016-Alliance comments (as member of the Venous Care Partnership) to AHRQ regarding Treatment Strategies for Patients with Lower Extremity Chronic Venous Disease (LECVD)
- May 2016-Alliance comments to CMS on Medicare Program; Part B Drug Payment Model
- March 2016-Alliance comments to CMS on CMS Quality Measure Development Plan
- March 2016-Alliance comments to CMS on MACRA Episode Groups
Health Care Fraud Investigations: What to do when the government knocks
We are inviting Alliance of Wound Care Stakeholders members to join speakers from Epstein Becker and Green for a complimentary webinar addressing the risks and risk management tools for wound care practitioners and manufacturers related to federal and state health care fraud enforcement under the federal False Claims Acts, including its “whistleblower” provisions.
Date: August 17, 2016 12 noon - 1:00 pm eastern time
Why Should You Care?
The U.S. Department of Justice (DOJ) recently announced that it is stepping up its use of the False Claims Act to investigate criminal activity in health care. Previously, most activity was limited to civil courts and involved only monetary recoupment. However, the DOJ is now often pursuing parallel criminal and civil investigations of health care fraud.
Who Should Care: Clinicians, Corporate Officers, Administrators and Manufacturers
On September 9, 2015, DOJ issued new guidance on individual accountability for corporate wrongdoing. In a memorandum by Deputy Attorney General Sally Q. Yates, (the “Yates Memorandum”) the DOJ provides 6 specific accountability criteria designed to guide fraud enforcement investigations. You need to know these criteria, because they may call for a shift in how you or your customers carry out your personal compliance obligations.
What will you learn?
This webinar will provide insight into expanding government investigations and offer ways to enhance your compliance efforts including:
- High risk health care fraud issues
- How to manage a 'touch' by the government enforcement players such as the receipt of a subpoena, and
- The current enforcement climate